<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02569905</url>
  </required_header>
  <id_info>
    <org_study_id>2014032605</org_study_id>
    <nct_id>NCT02569905</nct_id>
  </id_info>
  <brief_title>Effect of Parecoxib Sodium and Flurbiprofen Injection on Postoperative Shivering</brief_title>
  <official_title>Tumor Hospital of Guangxi Medical University, China</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Guangxi Medical University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Guangxi Medical University</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Shivering is an early postoperative complication during the postoperative recovery period,
      and there is no clear consensus about the best way for its prevention. The aim of the study
      was to compare the efficacy and accompanying side effects of prophylactic flurbiprofen with
      that of parecoxib or placebo for reducing postoperative shivering.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      154 patients with American Society of Anesthesiologists physical status I-II, who were
      scheduled for colorectal operation under general anesthesia, were randomly assigned to
      receive flurbiprofen (Group F), parecoxib sodium (Group P ) or normal saline(Group S)40min
      before the end of surgery. Hemodynamic parameters were monitored. The occurrence of shivering
      postoperative nausea and vomiting were recorded during the recovery period. And visual
      analogue score (VAS) and ramsy sedation scale (RSS) were also recorded.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>April 2014</start_date>
  <completion_date type="Actual">April 2015</completion_date>
  <primary_completion_date type="Actual">April 2015</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>shivering</measure>
    <time_frame>in one hour after extubation.</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>visual analogue score</measure>
    <time_frame>at the time of extubation, 30min and 60min after extubation.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>sedation scores</measure>
    <time_frame>at the time of extubation, 30min and 60min after extubation.</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>incidence of postoperative nausea and vomiting</measure>
    <time_frame>in one hour after extubation.</time_frame>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">166</enrollment>
  <condition>Postoperative Shivering</condition>
  <arm_group>
    <arm_group_label>Groups Parecoxib sodium</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fifty-one, American Society of Anesthesiologists' (ASA) physical status1or2, patients, undergoing colorectal operation were selected in the clinical study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Groups Flurbiprofen</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Fifty-two, American Society of Anesthesiologists' (ASA) physical status1or2, patients, undergoing colorectal operation were selected in the clinical study.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group Saline</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Fifty-one, American Society of Anesthesiologists' (ASA) physical status1or2, patients, undergoing colorectal operation were selected in the clinical study.</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>parecoxib sodium</intervention_name>
    <description>parecoxib sodium 40mg</description>
    <arm_group_label>Groups Parecoxib sodium</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>flurbiprofen</intervention_name>
    <description>flurbiprofen 50mg</description>
    <arm_group_label>Groups Flurbiprofen</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>saline</intervention_name>
    <description>normal saline</description>
    <arm_group_label>Group Saline</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  One hundred and sixty-six, American Society of Anesthesiologists' (ASA) physical
             status1or2, patients, undergoing colorectal operation were selected in the
             prospective, randomized, double-blind clinical study.

          -  All patients who were from 21 to 62 years old and body mass index 19-35 in tumor
             hospital of Guangxi medical university (State of China) from April 2014 to April 2015
             were included.

        Exclusion Criteria:

          -  Patients with cardiac, pulmonary, hepatic, renal, thyroid, or neuromuscular disease,
             and those who took chronic drug or abused alcohol were excluded.

          -  Another patients with hypertension, gastrointestinal bleeding, an initial core
             temperature &gt;37.5℃ or &lt;36.5℃, a history of allergy to non- steroidal anti-inflammatory
             drugs (NSAIDs) or other agents to be used, and inability to cooperate were also
             excluded in this study.

          -  Another patients with blood loss during operation&gt;400ml, a need for blood transfusion
             during surgery, duration of operation&gt;4h and surgical procedures changed were
             excluded.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>21 Years</minimum_age>
    <maximum_age>62 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Anesthesia Department, Tumor Hospital of Guangxi Medical University</name>
      <address>
        <city>Nanning</city>
        <state>Guangxi</state>
        <zip>530021</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <reference>
    <citation>Buggy DJ, Crossley AW. Thermoregulation, mild perioperative hypothermia and postanaesthetic shivering. Br J Anaesth. 2000 May;84(5):615-28. Review.</citation>
    <PMID>10844839</PMID>
  </reference>
  <reference>
    <citation>Kilbaş Z, Menteş MÖ, Harlak A, Yiğit T, Balkan SM, Coşar A, Öztürk E, Kozak O, Tufan CT. Efficacy of wound infiltration with lornoxicam for postoperative analgesia following thyroidectomy: a prospective, randomized, double-blind study. Turk J Med Sci. 2015;45(3):700-5.</citation>
    <PMID>26281342</PMID>
  </reference>
  <reference>
    <citation>Yang X, Peng N, Li N, Li J. Effect of cyclooxygenase-2-specific inhibitors on postoperative analgesia after major open abdominal surgery. Pain Manag Nurs. 2015 Jun;16(3):242-8. doi: 10.1016/j.pmn.2014.07.004.</citation>
    <PMID>26025794</PMID>
  </reference>
  <reference>
    <citation>Ayrian E, Kaye AD, Varner CL, Guerra C, Vadivelu N, Urman RD, Zelman V, Lumb PD, Rosa G, Bilotta F. Effects of Anesthetic Management on Early Postoperative Recovery, Hemodynamics and Pain After Supratentorial Craniotomy. J Clin Med Res. 2015 Oct;7(10):731-41. doi: 10.14740/jocmr2256w. Epub 2015 Aug 23. Review.</citation>
    <PMID>26345202</PMID>
  </reference>
  <reference>
    <citation>Yared JP, Starr NJ, Hoffmann-Hogg L, Bashour CA, Insler SR, O'Connor M, Piedmonte M, Cosgrove DM 3rd. Dexamethasone decreases the incidence of shivering after cardiac surgery: a randomized, double-blind, placebo-controlled study. Anesth Analg. 1998 Oct;87(4):795-9.</citation>
    <PMID>9768772</PMID>
  </reference>
  <reference>
    <citation>Li X, Zhou M, Xia Q, Li W, Zhang Y. Effect of parecoxib sodium on postoperative shivering: a randomised, double-blind clinical trial. Eur J Anaesthesiol. 2014 Apr;31(4):225-30. doi: 10.1097/01.EJA.0000436684.94403.1e.</citation>
    <PMID>24270900</PMID>
  </reference>
  <reference>
    <citation>Chen J, Chen Y, Lu KZ. Prophylactic parecoxib reduces the incidence of shivering after general anaesthesia. Eur J Anaesthesiol. 2014 Dec;31(12):714-5. doi: 10.1097/EJA.0000000000000165.</citation>
    <PMID>25335108</PMID>
  </reference>
  <reference>
    <citation>Shen H, Chen Y, Lu KZ, Chen J. Parecoxib for the prevention of shivering after general anesthesia. J Surg Res. 2015 Jul;197(1):139-44. doi: 10.1016/j.jss.2015.03.011. Epub 2015 Mar 28.</citation>
    <PMID>25908099</PMID>
  </reference>
  <reference>
    <citation>Teymourian H, Mohajerani SA, Bagheri P, Seddighi A, Seddighi AS, Razavian I. Effect of Ondansetron on Postoperative Shivering After Craniotomy. World Neurosurg. 2015 Dec;84(6):1923-8. doi: 10.1016/j.wneu.2015.08.034. Epub 2015 Sep 3.</citation>
    <PMID>26342782</PMID>
  </reference>
  <reference>
    <citation>Liu ZX, Xu FY, Liang X, Zhou M, Wu L, Wu JR, Xia JH, Zou Z. Efficacy of dexmedetomidine on postoperative shivering: a meta-analysis of clinical trials. Can J Anaesth. 2015 Jul;62(7):816-29. doi: 10.1007/s12630-015-0368-1. Epub 2015 Apr 8. Review.</citation>
    <PMID>25851018</PMID>
  </reference>
  <reference>
    <citation>Park SM, Mangat HS, Berger K, Rosengart AJ. Efficacy spectrum of antishivering medications: meta-analysis of randomized controlled trials. Crit Care Med. 2012 Nov;40(11):3070-82. doi: 10.1097/CCM.0b013e31825b931e. Review.</citation>
    <PMID>22890247</PMID>
  </reference>
  <verification_date>October 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 1, 2015</study_first_submitted>
  <study_first_submitted_qc>October 6, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">October 7, 2015</study_first_posted>
  <last_update_submitted>October 23, 2015</last_update_submitted>
  <last_update_submitted_qc>October 23, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 27, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Guangxi Medical University</investigator_affiliation>
    <investigator_full_name>xueke du</investigator_full_name>
    <investigator_title>anesthesiologists</investigator_title>
  </responsible_party>
  <keyword>flurbiprofen</keyword>
  <keyword>Parecoxib sodium</keyword>
  <keyword>Postoperative Shivering</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Flurbiprofen</mesh_term>
    <mesh_term>Parecoxib</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

